𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytokeratin subtypes and involucrin in squamous cell carcinoma of the vulva. An immunohistochemical study of 41 cases

✍ Scribed by Anca Ansink; Wolter J. Mooi; Greet Van Doornewaard; Harm Van Tinteren; A. Peter M. Heintz; Dagmar Ivanyi


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
600 KB
Volume
76
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background. Histologic grade seems to be of limited prognostic significance in patients with vulvar carcinoma. However, the study of cytokeratin expression is of potential interest because it allows a more precise evaluation of the degree of squamous differentiation. This study was was conducted to investigate whether differences in cytokeratin expression exist between normal vulvar epithelium and vulvar carcinoma and whether these differences are prognostically significant.

Methods. The expression of several differentiation markers, i.e., cytokeratin (CK) 10, CK 13, and involucrin, was studied in samples of 41 vulvar carcinomas. The expression of CK 8, 10, 13, and 14 was compared with CK expression in normal vulvar epithelium and was correlated with tumor grade and tumor growth pattern. Tumor growth pattern was considered type A if infiltrating tumor cell nests showed a layer of small, basaloid cells bordering the surrounding mesenchymal tissue and was considered type B if this was not the case. Prognosis was based on whether disease recurred or not.

Results. Sixteen patients had disease recurrence. No prognostic significance of tumor grade was found. Tumor growth pattern was prognostically significant: in patients with a type A tumor, recurrence was observed less often than in patients with a type B tumor (P = 0.03). Cytokeratin 14, typical for basal cells of normal vulvar epithelium, was expressed in all tumors, whereas CK 8 was not expressed in any tumor. A relationship between tumor growth pattern and the concordant expression of differentiation markers was observed in 55% of type A tumors and in no of type B tumors, concordant expression of CK 10, CK 13, and involucrin was found.

ConcIusion. The expression of differentiation markers in vulvar carcinoma is related strongly to the tumor


πŸ“œ SIMILAR VOLUMES


Squamous cell carcinoma of the vulva in
✍ Piura, Benjamin; Rabinovich, Alex; Cohen, Yoram; Friger, Michael; Glezerman, Mar πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 2 views

Background and Objectives: Vulvar carcinoma accounts for 4.9% of all female genital tract malignancies in the south of Israel. The most common histologic type is squamous cell carcinoma (82%). The purpose of this study was to investigate the clinical findings, treatment, and outcome of patients with

Risk factors for invasive squamous cell
✍ Birgitte S. Madsen; Helle L. Jensen; Adriaan J.C. van den Brule; Jan Wohlfahrt; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 106 KB

The etiology of vulvar and vaginal squamous cell carcinoma (VV-SCC) has received little attention. A total of 182 women with invasive VV-SCC (116 with VV-SCC vulva , 66 with VV-SCC vagina ), 164 uterine corpus cancer controls and 518 population controls were interviewed in a population-based case-co

Immunohistochemical study of the express
✍ Kanokporn Bhalang; Abdel H. Kafrawy; Dale A. Miles πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 397 KB πŸ‘ 1 views

## BACKGROUND. Human chorionic gonadotropin (hCG) is a glycoprotein hormone comprised of two dissimilar subunits (␣ and ␀) and normally is synthesized by trophoblastic tissue. Although hCG expression has been identified in a variety of neoplastic tissues, to the authors' knowledge no investigation

Evaluation of the prognostic significanc
✍ Gunnar B. Kristensen; Ruth Holm; Vera M. Abeler; Claes G. TropΓ© πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 700 KB

BACKGROUND. This study evaluated the prognostic significance of immunohistochemical staining for cathepsin D, epidermal growth factor receptor (EGFR). and c-erbB-2 in patients with early cervical squamous cell carcinoma. ## METHODS. This retrospective analysis comprised 132 patients, all subjecte